EP2268310
USE OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND DOXORUBICINE FOR TREATING NON-HODGKIN' S LYMPHOMAS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.3.2009EP published:
20.7.2016EP application number:
09723808.3
EPO information:
European Patent Register
Max expiry date:
22.3.2029
Title:
USE OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND DOXORUBICINE FOR TREATING NON-HODGKIN' S LYMPHOMAS
Timeline
Today
23.3.2009EP application
20.7.2016EP Publication
Owner
Name:
Roche Glycart AGAddress:
Wagistrasse 18, 8952, Schlieren-Zuerich, CH
Inventor
Name:
DUMONTET, CharlesAddress:
Venissieux, FR
Name:
FRIESS, ThomasAddress:
Diessen-Dettenhofen, DE
Name:
HERTING, FrankAddress:
Penzberg, DE
Name:
KLEIN, ChristianAddress:
Bonstetten, CH
Name:
UMANA, PabloAddress:
Wollerau, CH
Priority
Number:
08005554Date:
25.3.2008Country:
EP
Number:
08007172Date:
11.4.2008Country:
EP
Classification
Categories:
A61K 39/395, C07K 16/28, A61P 35/00